Woodline Partners LP Silence Therapeutics PLC Transaction History
Woodline Partners LP
- $14.3 Billion
- Q1 2025
A detailed history of Woodline Partners LP transactions in Silence Therapeutics PLC stock. As of the latest transaction made, Woodline Partners LP holds 134,492 shares of SLN stock, worth $836,540. This represents 0.0% of its overall portfolio holdings.
Number of Shares
134,492
Previous 498,732
73.03%
Holding current value
$836,540
Previous $3.43 Million
88.95%
% of portfolio
0.0%
Previous 0.03%
Shares
11 transactions
Others Institutions Holding SLN
# of Institutions
61Shares Held
22.7MCall Options Held
1.3KPut Options Held
2.6K-
Tcg Crossover Management, LLC Palo Alto, CA3.03MShares$18.9 Million2.06% of portfolio
-
Siren, L.L.C. New York, NY2.79MShares$17.4 Million0.45% of portfolio
-
Redmile Group, LLC San Francisco, CA2.21MShares$13.8 Million0.66% of portfolio
-
Morgan Stanley New York, NY2MShares$12.4 Million0.0% of portfolio
-
Lombard Odier Asset Management (Usa) Corp New York, NY1.85MShares$11.5 Million0.44% of portfolio
About Silence Therapeutics plc
- Ticker SLN
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,888,400
- Market Cap $223M
- Description
- Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...